Haleon (HLN) Cash from Investing Activities (2021 - 2023)

Haleon (HLN) posted Cash from Investing Activities of -$233.3 million for Q4 2023, up 97.68% on a QoQ basis from -$10.1 billion in Q4 2022, and up 97.68% year-over-year from -$118.0 million in Q4 2022.

Haleon (HLN) Cash from Investing Activities (2021 - 2023) Analysis & Trends

Haleon's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$233.3 million for Q4 2023.

  • Quarterly Cash from Investing Activities rose 97.68% year-over-year to -$233.3 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$20.3 billion (changed N/A YoY) and the FY2025 annual result came in at -$456.2 million, down 167.59% from the prior year.
  • Cash from Investing Activities was -$233.3 million for Q4 2023 at Haleon, up from -$10.1 billion in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $624.1 million in Q4 2021 and bottomed at -$10.6 billion in Q3 2022.
  • A 3-year average of -$5.1 billion and a median of -$5.2 billion in 2023 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 1713.76% — and 2023, when it jumped 97.68%.
  • Haleon's Cash from Investing Activities stood at $624.1 million in 2021, then sank by 1713.76% to -$10.1 billion in 2022, then soared by 97.68% to -$233.3 million in 2023.
  • Business Quant data shows HLN's Cash from Investing Activities at -$233.3 million in Q4 2023, -$10.1 billion in Q4 2022, and -$10.6 billion in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.78 Bn 87.91 Bn - -
2 Teva Pharmaceutical Industries 36.02 Bn 32.28 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.60 Bn 30.66 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.09 Bn 20.94 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.35 Bn 18.54 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.82 Bn 16.50 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn -60.00 Mn
10 Vireo Growth 10.51 Bn 10.36 Bn 59.30 Mn 8.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 -233.34 Mn
Dec 31, 2023 -233.34 Mn
Dec 31, 2022 -10.07 Bn
Dec 31, 2022 -10.07 Bn
Sep 20, 2022 -10.57 Bn
Sep 20, 2022 -10.57 Bn
Dec 31, 2021 624.13 Mn
Dec 31, 2021 624.13 Mn